Bulante, Baby Boy .

HRN: 27-59-78  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/12/2025
08/19/2025
IV
45mg
Q24h
PSNB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: